The People’s Broker
“In the jungle among the money funds, there is only one king.”
Those who have been in the investing game long enough will probably remember the slogan for the Dreyfus Fund, the top-performing mutual fund of the 1950s and -60s started by Jack Dreyfus. The ads for the fund featured a lion striding out of the Wall Street subway station and ran essentially unchanged for over 40 years.
Dreyfus himself was one of the kings of Wall Street, but he also had the common touch. His populist, take-it-to-the-people approach made him not only a financial pioneer (and a very rich man), but also a fierce advocate for the little guy.
In his memoir, The Lion of Wall Street, he wrote that steam came out of his ears whenever he felt that “the American people have been jerked around.”
Dreyfus was born exactly 100 years ago, on August 28, 1913, in Montgomery, Alabama. His early career was utterly undistinguished: by his own accounts, he was a lackluster student, both in high school and later at Lehigh University. He fumbled his way through jobs as a candy salesman and industrial designer before landing a kind of apprenticeship at a Wall Street brokerage firm—an apprenticeship that his father surreptitiously paid for.
After World War II, however, things started to happen. Dreyfus started his own brokerage firm in 1947, and then, four years later, hit upon the inspiration that would change the U.S. investment landscape: the mass-market mutual fund, geared towards individuals instead of large financial institutions. Such funds would, he hoped, give ordinary investors the opportunities previously enjoyed by professional financiers. Now he just needed to attract clients.
He had his work cut out for him. Back in the pre-IRA day, investing in the stock market was for high rollers and wheeler-dealers, not for ordinary families with their 401(k)s. Average Joes kept their money in their mattress, which is to say, in the bank, so Dreyfus learned to master the burgeoning art of advertising. His firm’s TV spots blended ebullience and earnestness: “The Dreyfus Fund hopes to make your money grow, and takes sensible risks in that direction.” “Christopher Columbus: America’s first speculator.”
It worked. The company exploded. Investor’s Business Daily shows the Dreyfus Fund as yielding 604% from 1953 to 1964, compared with 346% for the Dow Jones and 502% for the next-best fund. Life magazine did a spread on the “Wall Street Lion,” and later Barron’s would call Dreyfus the second-most-influential money manager of the 20th century.
It was at this point that Dreyfus had the first of many battles with Goliath of government institutions. Just after his firm premiered its trademark commercials featuring the king of the cats, the SEC passed a law forbidding TV spots for mutual funds. For years, the company was unable to air any new ads. The SEC later rescinded the law, but the episode doubtless confirmed Dreyfus in his opposition to bureaucracies that, in his view, denied ordinary citizens access to potentially beneficial information.
His greatest battle was yet to come. In the 1960s, Dreyfus began to suffer from severe depression, which he thought was caused by too much “electricity” in his body. Flawed reasoning, but strangely, it served him well: when he asked a doctor for a prescription for Dilantin (phenytoin), an epilepsy medication, the drug seemed to cure him almost overnight.
Thus began the crusade that would last the rest of his life. Convinced that the drug had medical uses beyond those for which it was commonly prescribed, he wrote an earnestly titled book, A Remarkable Medicine Has Been Overlooked, and began lobbying for further investigation of phenytoin’s benefits. His aim was to help people who suffered as he had, but he soon found his way blocked by a formidable opponent: the FDA.
It turned out that FDA regulations forbid so-called off-label uses of medications—i.e., prescribing drugs for ailments other than those they were designed to alleviate. No matter how beneficial a drug may be, companies and individual doctors cannot publicize its effects in the official literature if it hasn’t been specifically approved for a given purpose. In Dreyfus’s view, this hyper-cautious bureaucratic attitude caused millions of ordinary Americans to suffer needlessly: “Without FDA approval, drug companies cannot market phenytoin as anything other than an anticonvulsant, and most doctors remain in the dark as to its versatility…Millions of people in this country alone suffer because of the letters FDA.”
Dreyfus spent the next 30 years trying to persuade doctors, senators, even President Clinton himself to liberalize FDA regulations, but to little avail. The $100 million of his own money that he spent to promote phenytoin for other uses never succeeded in winning widespread approval for the medication, in part because its manufacturer, Parke-Davis, didn’t want to invest in a product whose patent was about to expire.
But if Dreyfus’s medical lobbying yielded little fruit, his legacy to ordinary investors was tremendous. His methods for managing his mutual fund, which included trading stocks rapidly, buying companies that are on the upswing regardless of their price, and close scrutiny of charts that track stock prices, have influenced countless major investors such as Charles Schwab and Ned Johnson. Meanwhile the popularization of the mutual fund as a financial product has changed retirement as we know it.
Jack Dreyfus was an American original. If an institution is the lengthened shadow of a single man, his shadow is long indeed.
(You can sign up for my free newsletter here.)
Posted by Eddy Elfenbein on August 27th, 2013 at 9:20 am
The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.
- Tweets by @EddyElfenbein
-
Archives
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- November 2005
- October 2005
- September 2005
- August 2005
- July 2005